Alpha Sense BI
MAY 5, 2023
2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.
Alpha Sense BI
APRIL 19, 2024
2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. OpenAI’s ChatGPT ). Having proven to be a catalyst for business growth, genAI is projected to boast a $1.3 Start your free trial today.
Engage3
MAY 19, 2022
He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Adi propelled the fastest growing division of the company and scaled its revenue 4x. Adi received his B.S. He holds B.A.
Expert insights. Personalized for you.
97 
Let's personalize your content